Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

MINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced...
September 30, 2025 08:45 ET | Source: Nuwellis, Inc.

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

ULTRA-Peds Registry Demonstrate 92% Treatment Survival in Children with AKI Fluid Overload or Congenital Kidney Failure
August 21, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug...
August 15, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it...
August 07, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
August 05, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

NUWELLIS ANNOUNCES THE FIRST SUCCESSFUL OUTPATIENT APPLICATION OF THE AQUADEX SMARTFLOW® SYSTEM UNDER NEW CMS CODE
August 04, 2025 17:24 ET | Source: Nuwellis, Inc.

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Stockholders Approve All Proposals at Special Meeting
July 17, 2025 07:35 ET | Source: Nuwellis, Inc.

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Announces Termination of REVERSE-HF Clinical Trial
October 03, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting

MINNEAPOLIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the results...
October 19, 2021 08:00 ET | Source: Nuwellis, Inc.

Nuwellis Selected as a Recipient of the Governor’s International Trade Award

EDEN PRAIRIE, Minn., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) was honored last week with the 2021 Governor's International Trade Award by Minnesota Governor Tim Walz. This...